FindTrial
Sign In

use of serum erythropoietin and arterial pco2 analysis in septic shock

Predictive utility of serum erythropoietin level combined with paco2 gap for morbidity and 28 days mortality in septic shock- a single center prospective observational study - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/04/108764
Enrollment
120
Registered
2026-04-20
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I788- Other diseases of capillaries

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil Intervention3: Nil: Nil Intervention4: Nil: Nil

Sponsors

Indira Gandhi istitute of medical sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)adherence to the sepsis & septic shock diagnostic criteria 2)completion of various labarotary tests according to sepsis guideline including erythropoietin and paco2 gap 3) all ages above 18 years

Exclusion criteria

Exclusion criteria: pregnancy and lactation Chronic kidney disease exogenous erythropoietin therapy malignant neoplasms undergoing chemo or radiotherapy

Design outcomes

Primary

MeasureTime frame
evaluate serum erythropoietin level combined with Paco2 gap as predictor for morbidity and 28 days mortalityTimepoint: 7 days,14 day, 4weeks—

Secondary

MeasureTime frame
erythropoietin and Paaco2 gap a better indicator than conventional markers 2) to evaluate total duration of vasopressure requiredTimepoint: 28 days—

Countries

India

Contacts

Public ContactRanjeet Rana De

Indira gandhi Institute of medical Sciences

ranjeet.igims2015@gmail.com7903696301

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026